Produkty 5492-28-4

CAS 5492-28-4 to numer rejestracyjny substancji (11beta)-11,17,21-Trihydroxy-pregna-1,4,8-triene-3,20-dione. Oferty producentów: TRC. Dostępne opakowania: 250mg.

(11beta)-11,17,21-Trihydroxy-pregna-1,4,8-triene-3,20-dione
TRC
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(10S,11S,13S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one (CAS 5492-28-4) to związek chemiczny o wzorze sumarycznym C21H26O5 i masie molowej 358.4 g/mol. Nazwa systematyczna IUPAC: (10S,11S,13S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one. InChIKey: FCNKNQPEOFYNPP-MROOVQBNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H26O5
Masa molowa358.4 g/mol
Nazwa IUPAC(10S,11S,13S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one
InChIKeyFCNKNQPEOFYNPP-MROOVQBNSA-N
SMILESC[C@]12C[C@@H](C3=C(C1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@@]43C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (11?)-11,17,21-Trihydroxy-pregna-1,4,8-triene-3,20-dione
Izomery (ten sam wzór sumaryczny)
3-[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]propane-1,2-diol C21H26O5
(1S,2S,4R,6S,7S,9S,10S,11R)-9-hydroxy-6-(2-hydroxyacetyl)-7,11-dimethyl-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadeca-12,15-dien-14-one C21H26O5
(8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one C21H26O5
(3S,3aR,9aR)-3-hexanoyl-9a-methyl-6-[(E)-prop-1-enyl]-3,3a,4,8-tetrahydrofuro[3,2-g]isochromene-2,9-dione C21H26O5
(1S,2S,4R,8S,9S,11S,12S,13R)-6,11-dihydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-7,16-dione C21H26O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one C21H26O5
(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C21H26O5
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H26O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one C21H26O5
2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H26O5
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C21H26O5
1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one C21H26O5